Breastfeeding Status and Duration and Infections, Hospitalizations for Infections, and Antibiotic Use in the First Two Years of Life in the ELFE Cohort.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
15 Jul 2019
Historique:
received: 31 05 2019
revised: 03 07 2019
accepted: 11 07 2019
entrez: 18 7 2019
pubmed: 18 7 2019
medline: 10 1 2020
Statut: epublish

Résumé

In low- and middle-income countries, the protective effect of breastfeeding against infections is well established, but in high-income countries, the effect could be weakened by higher hygienic conditions. We aimed to examine the association between breastfeeding and infections in the first 2 years of life, in a high-income country with relatively short breastfeeding duration. Among 10,349 young children from the nationwide Etude Longitudinale Française depuis l'Enfance (ELFE) birth cohort, breastfeeding and parent-reported hospitalizations, bronchiolitis and otitis events, and antibiotic use were prospectively collected up to 2 years. Never-breastfed infants were used as reference group. Any breastfeeding for <3 months was associated with higher risks of hospitalizations from gastrointestinal infections or fever. Predominant breastfeeding for <1 month was associated with higher risk of a single hospital admission while predominant breastfeeding for ≥3 months was associated with a lower risk of long duration (≥4 nights) of hospitalization. Ever breastfeeding was associated with lower risk of antibiotic use. This study confirmed the well-known associations between breastfeeding and hospitalizations but also highlighted a strong inverse association between breastfeeding and antibiotic use. Although we cannot infer causality from this observational study, this finding is worth highlighting in a context of rising concern regarding antibiotic resistance.

Identifiants

pubmed: 31311192
pii: nu11071607
doi: 10.3390/nu11071607
pmc: PMC6682893
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders of the ELFE survey had no role in the design of the present study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Références

JAMA. 2001 Jan 24-31;285(4):413-20
pubmed: 11242425
Am J Clin Nutr. 2003 Aug;78(2):291-5
pubmed: 12885711
J Nutr. 2005 Jan;135(1):1-4
pubmed: 15623823
Pediatrics. 2007 Apr;119(4):e837-42
pubmed: 17403827
BMC Pediatr. 2009 Sep 21;9:58
pubmed: 19772571
BMJ. 1990 Jan 6;300(6716):11-6
pubmed: 2105113
Early Hum Dev. 2013 Jun;89 Suppl 1:S51-7
pubmed: 23809352
Breastfeed Med. 2015 Jul-Aug;10(6):326-33
pubmed: 26110340
Acta Paediatr. 2015 Dec;104(467):85-95
pubmed: 26265016
JAMA Pediatr. 2016 Mar;170(3):267-87
pubmed: 26810619
Lancet. 2016 Jan 30;387(10017):475-90
pubmed: 26869575
JAMA Pediatr. 2016 Aug 1;170(8):750-7
pubmed: 27294842
Curr Allergy Asthma Rep. 2016 Sep;16(9):68
pubmed: 27595154
PLoS One. 2017 Feb 23;12(2):e0172763
pubmed: 28231310
Curr Allergy Asthma Rep. 2017 Jul;17(7):45
pubmed: 28589514
J Pediatr Gastroenterol Nutr. 2017 Aug;65(2):225-231
pubmed: 28737571
Ther Adv Respir Dis. 2017 Oct;11(10):393-401
pubmed: 28812472
Midwifery. 2019 Feb;69:67-75
pubmed: 30399510
Nutr Diet. 2019 Apr 22;:null
pubmed: 31012243
Acta Paediatr. 1994 Jul;83(7):714-8
pubmed: 7949800

Auteurs

Camille Davisse-Paturet (C)

Université de Paris, CRESS, INSERM, INRA F-75004 Paris, France. camille.davisse-paturet@inserm.fr.

Karine Adel-Patient (K)

UMR Service de Pharmacologie et Immunoanalyse, CEA, INRA, Université Paris-Saclay, 91191 Gif-sur-Yvette, France.

Amandine Divaret-Chauveau (A)

Unité d'allergologie pédiatrique, Hôpital d'enfants, CHRU de Nancy, 54500 Vandoeuvre-lès-Nancy, France.
EA3450,DevAH-Department of Physiology, Faculty of Medicine, University of Lorraine, 54500 Vandoeuvre-lès-Nancy, France.

Juliette Pierson (J)

Université de Paris, CRESS, INSERM, INRA F-75004 Paris, France.

Sandrine Lioret (S)

Université de Paris, CRESS, INSERM, INRA F-75004 Paris, France.

Marie Cheminat (M)

Ined, Inserm, Joint Unit Elfe, F-75020 Paris, France.

Marie-Noëlle Dufourg (MN)

Ined, Inserm, Joint Unit Elfe, F-75020 Paris, France.

Marie-Aline Charles (MA)

Université de Paris, CRESS, INSERM, INRA F-75004 Paris, France.
Ined, Inserm, Joint Unit Elfe, F-75020 Paris, France.

Blandine de Lauzon-Guillain (B)

Université de Paris, CRESS, INSERM, INRA F-75004 Paris, France. blandine.delauzon@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH